Sugi Predict

Sugi Predict / Compounds / SCHEMBL108329

SCHEMBL108329

SCHEMBL108329

O=[N+]([O-])c1ccc(Nc2ccc(Nc3ccccc3)c(S(=O)(=O)O)c2)c([N+](=O)[O-])c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NT5E P21589 1/20 0.61
▸ MAPT P10636 8/20 0.57
▸ MEN1 O00255 6/20 0.57
▸ KMT2A Q03164 6/20 0.57
▸ MAPK1 P28482 4/20 0.57
▸ GFER P55789 2/20 0.57
▸ TDP1 Q9NUW8 5/20 0.55
▸ POLB P06746 3/20 0.55
▸ L3MBTL1 Q9Y468 5/20 0.54
▸ ALDH1A1 P00352 3/20 0.54
▸ HCAR3 P49019 1/20 0.53
▸ CTSV O60911 1/20 0.53
▸ CTSL P07711 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.52
▸ NSD2 O96028 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ APEX1 P27695 1/20 0.52
▸ APOBEC3A P31941 1/20 0.52
▸ RECQL P46063 1/20 0.52
▸ CASP6 P55212 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16147671 1.00 NT5E (0.61) NT5EMAPTMEN1KMT2AMAPK1
SCHEMBL141078 0.99 NT5E (0.60) NT5EMAPTMEN1KMT2AMAPK1
SCHEMBL141080 0.99 NT5E (0.60) NT5EMAPTMEN1KMT2AMAPK1
SCHEMBL141081 0.99 NT5E (0.60) NT5EMAPTMEN1KMT2AMAPK1
SCHEMBL7820869 0.89 NT5E (0.67) NT5EMAPTMEN1KMT2AGFER
SCHEMBL112129 0.88 TDP1 (0.62) NT5EMAPTMEN1KMT2AMAPK1
SCHEMBL456694 0.88 TDP1 (0.62) NT5EMAPTMEN1KMT2AMAPK1
SCHEMBL141079 0.88 MAPT (0.57) MAPTMEN1KMT2AMAPK1GFER
SCHEMBL29357322 0.88 MAPT (0.57) MAPTMEN1KMT2AMAPK1GFER
SCHEMBL13588699 0.87 TDP1 (0.54) NT5EMAPTMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200289667-A1 Targeting Macrophages to Modulate Electrical Conduction in the Heart THE GENERAL HOSPITAL CORPORATION 2020-09-17 — — US claimed
US-20190054184-A1 Targeting Macrophages to Modulate Electrical Conduction in the Heart THE GENERAL HOSPITAL CORPORATION 2019-02-21 — — US claimed
WO-2017139757-A1 TARGETING MACROPHAGES TO MODULATE ELECTRICAL CONDUCTION IN THE HEART THE GENERAL HOSPITAL CORPORATION (US) 2017-08-17 — — WO claimed
US-20230139684-A1 COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 — — US disclosed
US-20200289667-A1 Targeting Macrophages to Modulate Electrical Conduction in the Heart THE GENERAL HOSPITAL CORPORATION 2020-09-17 — — US disclosed
US-20190054184-A1 Targeting Macrophages to Modulate Electrical Conduction in the Heart THE GENERAL HOSPITAL CORPORATION 2019-02-21 — — US disclosed
US-10064842-B2 KCNQ channels as therapeutic targets WASHINGTON UNIVERSITY (US) 2018-09-04 — — US disclosed
WO-2017139757-A1 TARGETING MACROPHAGES TO MODULATE ELECTRICAL CONDUCTION IN THE HEART THE GENERAL HOSPITAL CORPORATION (US) 2017-08-17 — — WO disclosed
EP-2424491-B1 FILM FORMER IN HAIR COLOURS HENKEL AG & CO KGAA (DE) 2017-05-24 — — EP disclosed
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 — — US disclosed
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 — — US disclosed
EP-1257249-A1 DIAMINOPYRAZOLE DERIVATIVES AND OXIDATION HAIR DYE CONTAINING PYRAZOLONE DERIVATIVES Wella Aktiengesellschaft (DE) 2002-11-20 — — EP disclosed
WO-2002069918-A1 DIAMINOPYRAZOLE DERIVATIVES AND OXIDATION HAIR DYE CONTAINING PYRAZOLONE DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2002-09-12 — — WO disclosed
WO-2002069919-A1 OXIDATION DYE WELLA AKTIENGESELLSCHAFT (DE) 2002-09-12 — — WO disclosed
US-20020000012-A1 Compositions and methods for dyeing keratin fibers, especially hair WELLA AKTIENGESELLSCHAFT (DE) 2002-01-03 — — US disclosed
EP-1037593-A1 AGENT AND METHOD FOR DYEING FIBRES Wella Aktiengesellschaft (DE) 2000-09-27 — — EP disclosed
WO-2000021496-A1 AGENT AND METHOD FOR DYEING FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2000-04-20 — — WO disclosed
EP-0889719-A1 AGENTS FOR DYING AND DECOLORIZING FIBERS Wella Aktiengesellschaft (DE) 1999-01-13 — — EP disclosed
WO-1998022078-A1 AGENTS FOR DYING AND DECOLORIZING FIBERS WELLA AKTIENGESELLSCHAFT (DE) 1998-05-28 — — WO disclosed
US-4289496-A LOW LIQUID TO MATERIAL RATIO RESULTING IN UNIFORMITY OF FINISHING SANDOZ LTD. (CH) 1981-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139684-A1 COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS SERPINB1, DNASE1, PON1 NT5E 1457/4885MAPT 2144/4885MEN1 3530/4885
US-20020000012-A1 Compositions and methods for dyeing keratin fibers, especially hair KRT18, DSG1, KRTCAP2 NT5E 3354/4885MAPT 305/4885MEN1 4042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.